The diagnostic statistics regarding prostate cancer are staggering. One in every seven men will face this disease during his lifetime and the number jumps to one in five for African-American males.
Early detection and treatment are crucial, especially for men with a family history of this condition and those of African-American descent. Both groups are advised to begin screening at age 40 and have regular checkups. However, many are uninformed and those who are aware of the risks sometimes delay in getting screened.
In honor of Prostate Cancer Awareness Month in September, the National Football League Alumni Association and LabCorp are joining forces with Cancer Centers of America to provide free and discounted PSA (Prostate Specific Antigen) screenings beginning on September 1 and going through October 15. One of the first signs of being at risk of prostate cancer is elevated PSA levels. However, an elevated PSA level is not a cancer diagnosis, but it is an indicator that a thorough check-up by a medical professional is in order.
Through this program, 2,000 men over the age of 40 who fulfill the criteria will receive a free PSA screening at one of LabCorp’s 1,750 locations in the US and subsequently, others who qualify will receive a discounted screening for $25 through the end of the registration period. Those interested in signing up can visit Prostate Pep Talk to sign up through October 15.
An August 30 press conference in New Jersey will kick-off the initiative with speakers from the NFL, and members of Cancer Centers of America and LabCorp will also be present. Other related events will be held in cities around the country including Atlanta, Chicago, Phoenix, and Tulsa.
Cancer Centers of America, with five locations throughout the US, specializes in treating adults undergoing cancer treatment. Their advanced multi-prong approach to cancer treatment includes genomic testing, surgery, and immunotherapy, among others.
Cancer Centers of America offers not just medical support, but also emotional support to cancer patients and their families and consistently rank in the top percentage of patient approval and satisfaction surveys. They offer supportive proven therapies to allow patients to maintain a quality of life and manage difficult side effects which continue post-treatment. They have “a passion to care.”